Physician profile
Paul E Pinson
NPI 1265431035
$905.14
in general payments reported to CMS, 2019-2025
14 companies · $15.29 in 2025
The $15.29 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $183 · 2021: $107 · 2022: $115 · 2023: $110 · 2024: $138 · 2025: $15.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $270.65 | 2019-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $181.01 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.72 | 2019-2024 | Relistor |
| Biodelivery Sciences International, INC. | $56.94 | 2019-2021 | |
| Boston Scientific Corporation | $49.72 | 2024 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $49.12 | 2020-2021 | |
| Daiichi Sankyo INC. | $37.09 | 2019 | |
| Abbott Laboratories | $33.67 | 2023 | Proclaim |
| Grt US Holding, INC. | $32.37 | 2022 | |
| Shionogi INC | $30.24 | 2019 | |
| Abbvie INC. | $22.92 | 2023 | |
| Assertio Therapeutics, INC. | $18.30 | 2019 | |
| Pacira Therapeutics, INC. | $16.07 | 2019 | |
| Redhill Biopharma INC. | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Pinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.